Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


ArQule, Inc. 

19 Presidential Way

Woburn  Massachusetts  01801  U.S.A.
Phone: 781-994-0300 Fax: 781-376-6019



Drug Discovery



Pfizer Inc. 

Daiichi Sankyo, Inc. 

 Company News
ArQule, Inc. (ARQL) Announces Data Presentations With Tivantinib To Be Featured At American Society of Clinical Oncology 2014 6/2/2014 7:35:01 AM
ArQule, Inc. (ARQL) To Present At Jefferies and Co. Global Healthcare Conference 5/29/2014 8:05:49 AM
ArQule, Inc. (ARQL) Reports First Quarter 2014 Financial Results 5/7/2014 8:18:21 AM
ArQule, Inc. (ARQL) To Report First Quarter 2014 Financial Results On May 7, 2014 4/30/2014 9:14:20 AM
ArQule, Inc. (ARQL) To Present At Needham 13th Annual Healthcare Conference 4/2/2014 7:45:15 AM
ArQule, Inc. (ARQL) Reports Fiscal 2013 Year End And Fourth Quarter Results 3/5/2014 9:01:20 AM
ArQule, Inc. (ARQL) To Report Fiscal 2013 Financial Results On March 5, 2014 2/26/2014 7:39:48 AM
ArQule, Inc. (ARQL) To Present At RBC Capital Markets Healthcare Conference 2/18/2014 6:46:17 AM
ArQule, Inc. (ARQL) Announces Commencement Of Phase 3 Clinical Trial With Tivantinib In Hepatocellular Carcinoma By Partner Kyowa Hakko Kirin In Japan 2/4/2014 9:46:24 AM
ArQule, Inc. (ARQL) Soars As FDA Panel Favors Continuation Of Liver Cancer Drug Study, Stock Up +6.78% At Market Close (January 17, 2014) 1/17/2014 8:28:01 AM